Product Information | |
---|---|
Catalog#: | MK0935H |
Product Name: | Recombinant Human CD19 Protein, LIgG2b Fc-tagged, low endotoxin |
Product Overview: | Recombinant Human CD19 Protein, LIgG2b Fc-tagged, low endotoxin is expressed from human 293 cells (HEK293). It contains AA Pro 20 - Lys 291 (Accession # P15391-1). Predicted N-terminus: Pro 20. This protein carries a llama IgG2b Fc tag at the C-terminus. The protein has a calculated MW of 57.9 kDa. The protein migrates as 70-100 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation. |
Source: | HEK293 |
Species: | Human |
Tag: | LIgG2b Fc |
Formulation: | Lyophilized from 0.22 μm filtered solution in PBS, pH7.4. Normally trehalose is added as protectant before lyophilization. |
Bio-activity: | Immobilized FMC63 at 0.5 μg/mL (100 μL/well) can bind Recombinant Human CD19 Protein, LIgG2b Fc-tagged, low endotoxin with a linear range of 0.078-1.25 μg/mL (QC tested). |
Protein length: | Pro 20 - Lys 291 |
Purity: | >95% as determined by SDS-PAGE. |
Storage: | For long term storage, the product should be stored at lyophilized state at -20 centigrade or lower. |
Reconstitution: | It is recommended that sterile water be added to the vial to prepare a stock solution of 0.2 mg/ml. Centrifuge the vial at 4 centigrade before opening to recover the entire contents. |
Molecular Mass: | 57.9 kDa |
Stability: | No activity loss is observed after storage at: 4-8 centigrade for 12 months in lyophilized state; -70 centigrade for 3 months under sterile conditions after reconstitution. |
Endotoxin: | Less than 0.01 EU per μg by the LAL method. |
Enter your email here to subscribe